Lab
Caldwell Toxicology Labs LLC
Caldwell Toxicology Labs LLC was paid $419K by Medicaid between Jan 2018 and Jan 2021, across 79 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 44% of everything it billed.
33Billing provider infoCALDWELL TOXICOLOGY LABS LLC
TULSA, OK 74136
TULSA, OK 74136
33aNPI1700213667assigned 10/08/2013
33bProvider typeClinical Medical Laboratory
28Total paid$419K
24GClaims18,625
24DCodes billed79
24AFirst – last monthJan 2018 – Jan 2021
Compared with peers
Next to other Clinical Medical Laboratory providers in Oklahoma
Rank by total paid#18 of 46
Median peer was paid$248K
This provider vs. median1.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,556 | $92K | |
| 2019 | 5,489 | $72K | |
| 2020 | 6,535 | $255K | |
| 2021 | 45 | $337.34 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 44% | 1,863 | 812 | $186K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 8.8% | 1,768 | 764 | $37K |
| 80050 | General health panel | 5.3% | 620 | 609 | $22K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5.0% | 449 | 410 | $21K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.3% | 1,454 | 1,194 | $9K |
| 80061 | Lipid panel | 2.1% | 762 | 728 | $9K |
| 80053 | Comprehensive metabolic panel | 1.9% | 929 | 833 | $8K |
| 82670 | 1.3% | 232 | 231 | $6K | |
| 83068 | 1.3% | 726 | 687 | $6K | |
| 84403 | 1.3% | 242 | 238 | $5K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1.2% | 393 | 369 | $5K |
| 82172 | 1.1% | 307 | 284 | $5K |
67 more codes
| 84439 | 1.1% | 615 | $5K | |
| 84481 | 1.1% | 337 | $4K | |
| 82627 | 1.1% | 229 | $4K | |
| 84270 | 1.0% | 228 | $4K | |
| 84146 | <1% | 230 | $4K | |
| 83001 | <1% | 233 | $4K | |
| 83002 | <1% | 230 | $4K | |
| 82533 | <1% | 233 | $3K | |
| 83003 | <1% | 223 | $3K | |
| 84432 | <1% | 228 | $3K | |
| 86800 | <1% | 227 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 59 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 407 | $3K |
| 82728 | <1% | 247 | $3K | |
| 84144 | <1% | 151 | $3K | |
| 86376 | <1% | 197 | $3K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 36 | $3K |
| 87634 | <1% | 36 | $2K | |
| 83525 | <1% | 246 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 250 | $2K |
| 82157 | <1% | 190 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 73 | $2K |
| 83735 | <1% | 290 | $2K | |
| 83550 | <1% | 211 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 59 | $1K |
| 83540 | <1% | 221 | $1K | |
| 87581 | <1% | 36 | $1K | |
| 87486 | <1% | 36 | $1K | |
| 87640 | <1% | 36 | $1K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 36 | $1K |
| 87541 | <1% | 36 | $1K | |
| 87641 | <1% | 36 | $1K | |
| 84100 | <1% | 292 | $1K | |
| 82977 | <1% | 183 | $1K | |
| 83690 | <1% | 184 | $1K | |
| 86762 | <1% | 56 | $1K | |
| 86803 | <1% | 72 | $1K | |
| 82550 | <1% | 179 | $964.06 | |
| 84550 | <1% | 238 | $906.76 | |
| 83615 | <1% | 183 | $905.16 | |
| 87503 | <1% | 36 | $893.11 | |
| 82248 | <1% | 199 | $837.31 | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | <1% | 96 | $812.40 |
| 80164 | <1% | 65 | $746.48 | |
| 84480 | <1% | 77 | $729.03 | |
| 84436 | <1% | 120 | $572.15 | |
| 80076 | <1% | 75 | $542.87 | |
| 86706 | <1% | 42 | $502.85 | |
| 82607 | <1% | 66 | $493.79 | |
| 82150 | <1% | 95 | $477.36 | |
| 86850 | <1% | 54 | $392.52 | |
| 80177 | <1% | 32 | $377.28 | |
| 83090 | <1% | 29 | $376.86 | |
| 82746 | <1% | 48 | $343.39 | |
| 86141 | <1% | 44 | $342.81 | |
| 82947 | <1% | 75 | $303.97 | |
| 86592 | <1% | 59 | $258.90 | |
| 84153 | <1% | 14 | $231.64 | |
| 86901 | <1% | 56 | $209.72 | |
| 81001 | <1% | 67 | $182.72 | |
| 84134 | <1% | 14 | $181.72 | |
| 86900 | <1% | 56 | $177.84 | |
| 85018 | <1% | 56 | $153.04 | |
| 84479 | <1% | 39 | $99.62 | |
| 85014 | <1% | 12 | $25.32 | |
| G0471 | Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) | 0% | 33 | $0.00 |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 0% | 32 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGATES, ROBERT (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Alpha Medical Laboratory LLC | Tulsa, OK | $1.23M |
| Eyesight Healthcare, PLLC | Corpus Christi, TX | $12K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.